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Abstract
Engineered polyketide synthases (PKSs) are promising synthetic biology platforms for the production of chemicals with 
diverse applications. The dehydratase (DH) domain within modular type I PKSs generates an α,β-unsaturated bond in nas-
cent polyketide intermediates through a dehydration reaction. Several crystal structures of DH domains have been solved, 
providing important structural insights into substrate selection and dehydration. Here, we present two DH domain structures 
from two chemically diverse PKSs. The first DH domain, isolated from the third module in the borrelidin PKS, is specific 
towards a trans-cyclopentane-carboxylate-containing polyketide substrate. The second DH domain, isolated from the first 
module in the fluvirucin  B1 PKS, accepts an amide-containing polyketide intermediate. Sequence-structure analysis of these 
domains, in addition to previously published DH structures, display many significant similarities and key differences pertain-
ing to substrate selection. The two major differences between BorA DH M3, FluA DH M1 and other DH domains are found 
in regions of unmodeled residues or residues containing high B-factors. These two regions are located between α3–β11 and 
β7–α2. From the catalytic Asp located in α3 to a conserved Pro in β11, the residues between them form part of the bottom 
of the substrate-binding cavity responsible for binding to acyl-ACP intermediates.
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Introduction
Polyketide natural products are one of the largest classes 
of secondary metabolites, possessing vast structural and 
chemical diversity. The collinear biosynthetic logic of 
type I modular polyketide synthases (PKSs) make them a 
promising synthetic biology platform for the production 
of existing and novel compounds. The dehydratase (DH) 
domain within type 1 modular PKSs is responsible for 
the dehydration of specific C-3 hydroxyacyl-acyl carrier 
protein (ACP) intermediates, resulting in a correspond-
ing enoyl-ACP [42]. These unsaturated ACP-tethered 
intermediates can be either reduced by an associated 
enoyl reductase (ER) domain or result in the production 
of alkenes in even-to-odd positions in the final polyke-
tide structure [9]. The dehydratase domain from type 1 
modular PKSs contains a canonical double hot-dog fold 
motif with an invariant His/Asp catalytic dyad. These 
structural features are well conserved and well depicted 
in DH domain crystal structures from erythromycin [25], 
curacin [3, 15], rifamycin [17] and the gephyronic acid 
PKSs [9]. Despite having several crystal structures of DH 
domains, the structural basis for substrate selectivity and 
specificity is not completely understood. There is a need 
to understand substrate selection to enable effective design 
of synthetic PKSs with different DH substrates. Two main 
factors important for substrate selection by DH domains 
include the stereochemistry of the C-3 hydroxyacyl group 
and the chemical structure of the acyl-ACP intermediate 
past the C-3 hydroxyacyl position. Dehydration proceeds 
via a syn-coplanar elimination of water and is, therefore, 
sensitive to the stereochemical configuration of the C-3 
hydroxyacyl-ACP substrate [37], which is determined 
enzymatically by the ketoreductase (KR) domain within 
the module. Thus, DH domains are tied to KR domains 
that precede them biochemically [5].
The least understood factor in DH substrate selection 
is the length and chemical structure of the moiety past the 
C-3 hydroxyl group of the acyl-ACP intermediate. The 
structure and length of the acyl-ACP intermediate are 
determined by the upstream PKS module enzymatic archi-
tecture and the diverse starter-units incorporated in the 
nascent polyketide intermediate. How DH domains accom-
modate these diverse chemical structures while acting on 
the conserved C-3 hydroxyacyl position of the substrate 
remains unclear. To further understand substrate selection 
by DH domains, we conducted a sequence-structure anal-
ysis between DH domains from two chemically diverse 
modular type I PKSs. We chose to investigate two PKSs 
with distinct starter units and diverse enzymatic architec-
ture: the macrolactone-producing borrelidin (3) PKS, and 
the macrolactam-producing fluvirucin  B1 (6) PKS (Fig. 1, 
Fig. S1). The borrelidin PKS from Streptomyces parvulus 
Tü4055 utilizes a rare trans-cyclopentane-1,2-dicarboxy-
late starter unit (Fig. 1a, Fig. S1A) [31]. To date, there are 
very few PKSs identified that are able to incorporate and 
extend a carboxylate-containing polyketide intermediate. 
The fluvirucin  B1 PKS utilizes amide-containing dipepti-
dyl intermediate 4 (Fig. 1b, Fig. S1B), likely derived from 
l-aspartic acid and l-alanine [7, 27, 29]. Here, we present 
the crystal structures of the borrelidin DH domain from 
module 3 (BorA DH M3) and the fluvirucin  B1 DH domain 
from module 1 (FluA DH M1) at 1.80 Å and 2.01 Å, 
respectively. The BorA DH M3 is specific towards trans-
cyclopentane-carboxylate-containing polyketide substrate 
1, while the FluA DH M1 accepts amide-containing dipep-
tide polyketide intermediate 4 (Fig. 1). The DH mono-
mers from both BorA DH M3 and FluA DH M1 possess 
the traditional double-hotdog fold with an invariant His/
Asp catalytic dyad. A close inspection of both BorA DH 
A
B
Fig. 1  Corresponding substrates (1, 4) and product intermediates (2, 
5) for the BorA DH M3 and FluA DH M1. The final polyketide prod-
ucts are illustrated on the right (3, 6). a The borrelidin PKS utilizes 
a trans-cyclopentane-dicarboxylate starter unit (highlighted in red) 
and b the fluvirucin  B1 PKS accepts an amide-containing polyketide 
starter unit (highlighted in blue). The dehydration reaction is high-
lighted in yellow. The full biosynthetic polyketide synthase pathways 
for borrelidin and fluvirucin  B1 are depicted in Fig. S1 (colour figure 
online)
Journal of Industrial Microbiology & Biotechnology 
1 3
M3 and FluA DH M1 reveal key structural differences in 
flexible regions, as observed by high-B-factor analysis, 
located in the substrate-binding region. In silico docking 
with their native substrates further supports the impor-
tance of these flexible regions. In addition, we aligned DH 
domain sequences within the ClusterCAD database [13] 
to identify residues and structural regions that may play a 
role in substrate binding.
Results
Structure analysis
The BorA DH M3 and FluA DH M1 possess the conven-
tional double-hotdog fold homologous to previously deter-
mined type 1 DH domains from the erythromycin, cura-
cin, rifamycin and gephyronic acid PKSs (Fig. 2a, b) [3, 
A B
C D
E
F
Fig. 2  Structure of the BorA DH M3 and FluA DH M1. Overall 
structure of the BorA DH M3 colored in red a and the FluA DH M1 
colored in blue b. B-factor putty representation of BorA DH M3 c 
and FluA DH M1 d, where thin, blue tubes correspond to low B-fac-
tors and thicker, darker red tubes correspond to higher B-factors. e 
Structural alignment of the BorA DH M3 and FluA DH M1. Colored 
regions correspond to regions of higher α-carbon backbone deviation. 
f Close-up of e displaying the His/Asp catalytic dyad and the disor-
dered region between α3 and β11, which form part of the substrate-
binding cavity (colour figure online)
 Journal of Industrial Microbiology & Biotechnology
1 3
9, 17, 25]. Both BorA DH M3 and FluA DH M1 maintain 
the canonical His/Asp catalytic dyad (Fig. 2f) and share a 
sequence identity of 45.0%. Structural alignment between 
the BorA DH M3 and FluA DH M1 display minimal struc-
tural deviation within the double-hotdog motif (Fig. 2e). 
Cα superposition results in RMSD values of 1.29 Å within 
209 residues. As reference with other type I DH domains, 
both BorA DH M3 and FluA DH M1 share a sequence iden-
tity of 45.5% with the erythromycin module 4 DH domain. 
Cα superposition between the erythromycin module 4 
DH domain with either BorA DH M3 and FluA DH M1 
results in RMSD values of 1.70 and 1.69 Å over a span 
of 236 residues. Compared to the dual-functioning dehy-
dratase/isomerase DH domain from the gephyronic acid 
pathway, both BorA DH M3 and FluA DH M1 share 25.6% 
sequence identity. Cα superposition between the GphF DH1 
and either BorA DH M3 or FluA DH M1 results in higher 
RMSD values of 2.32 and 2.42 Å over a span of 226 resi-
dues. The increase in structural differences between BorA 
DH M3, FluA DH M1 and GphF DH1 are not surprising, 
given that GphF DH1 has greater separation within the His/
Asp catalytic dyad and other conserved residues surrounding 
the catalytic region [9].
Most of the structural deviations between BorA DH M3, 
FluA DH M1 and other DH domains are evident in multiple 
loop regions connecting the α-helices and β-sheets of the 
core double-hotdog motif (Fig. 2e). Small loops connecting 
β1–β2, β5–β6, β6–β7 and β12–β13 displayed small structural 
deviations. However, the largest deviations were located in 
two loop regions connecting β7–α2 and α3–β11 (Fig. 2F, 
Fig. S2). This was further supported by either high B-factors 
within these residues or missing electron density for residues 
in the loop region (Fig. 2c, d). In the case of BorA DH M3, 
we were unable to model 11 residues between α3 and β11, 
suggesting a highly flexible region within the DH domain 
(Fig. S2A). A lack of modeled residues between α3 and β11 
is also observed in the erythromycin M4, phthiocerol dimy-
cocerosate, curacin F and the rifamycin M10 DH domains 
(Fig. S2C, E, G, I). Unlike the BorA DH M3, all residues 
between α3 and β11 were modeled in the FluA DH M1 (Fig. 
S2B). A closer inspection of the residues between α3 and 
β11 FluA DH M1 displayed partially higher B-factors. These 
higher B-factors between α3 and β11 FluA DH M1 are also 
observed in the curacin H, J, K and gephyronic acid DH 
domains (Fig. S2D, F, H, J). Overall, B-factor analysis and 
lack of electron density between α3–β11 and β7–α2 in type 
I DH structures suggest a highly flexible region within the 
domain.
Substrate‑binding cavity
Structural and biochemical data suggest the DH substrate 
selection is based on DH/ACP protein–protein interactions, 
stereospecificity of the 3-hydroxyl group and substrate speci-
ficity (Fig. S3) [14, 16, 25, 30]. Within each DH monomer, 
the substrate-binding cavity contains (1) a hydrophobic 
tunnel/phosphopantetheine (PPant)-binding region, (2) a 
catalytic region and (3) an acyl intermediate-binding region 
(Fig. 3). The PPant-binding region is located at the surface 
of the DH domain between the β11 and β4, in close proxim-
ity to β14. An invariant arginine residue on the C-terminal 
end of β14 has been examined and proposed to be impor-
tant for either ACP docking and/or PPant recognition [6, 25, 
30]. An alignment of BorA DH M3 and FluA DH M1 with 
other type 1 DH domains displays the conserved arginine 
residue on the surface of the DH domain (Fig. S4). Meas-
urement between the α-carbon of the conserved Arg and 
the α-carbon of the catalytic His is on average 17.8 Å (Fig. 
S4A–B). This highly conserved distance can accommodate 
the smaller PPant-tethered 3-hydroxyacyl intermediate to 
the catalytic region. On average, the distance between the 
phosphate group of the PPant and the C-3 hydroxyl position 
is 16.4 Å. This is evident in the co-crystal structure of PpsC 
DH complexed with trans-dodec-2-enoyl-CoA (Fig. S4C–E) 
[14]. These results suggest that the Arg and the residues 
outlining the substrate tunnel towards the catalytic region 
in BorA DH M3 and FluA DH M1 are highly conserved 
amongst type 1 DH domains and may interact extensively 
with the PPant moiety of the ACP-tethered substrate.
The catalytic region of the DH domain contains the cata-
lytic His and Asp dyad responsible for the dehydration reac-
tion via a syn-coplanar elimination of water. In addition to 
the catalytic His and Asp, both BorA DH M3 and FluA DH 
M1 contain conserved Leu and Tyr residues that outline the 
catalytic region, the latter orienting a water molecule (Fig. 
S5). The catalytic His is located at the beginning of β3 and is 
on average less than 3.8 Å away from the Asp, located within 
α3. Recent findings in the fostriecin DH domain suggest DH 
domains utilize a single-base mechanism, where the active 
site His residue acts as the base to deprotonate C-2, subse-
quently protonating the C-3 hydroxyl group to promote C–O 
bond-cleavage and elimination of water [42]. The carboxy-
late group of the Asp likely binds and orients the hydroxyl 
group of the substrate in the favored conformation [42].
The acyl intermediate-binding region can be defined as 
the residues outlining the bottom of the substrate-binding 
cavity, outside of the catalytic region. These residues bind 
to the chemical moiety past the C-3 hydroxyacyl group of 
acyl-ACP intermediate. The polyketide intermediate past 
the C-3 hydroxyacyl group can vary in chemical structure, 
length, and atom heterogeneity, and is dependent on both 
the upstream PKS module enzymatic architecture and the 
diverse starter-units incorporated in the nascent polyketide 
intermediate. The BorA DH M3 can select for a cyclopen-
tane-carboxylate-containing intermediate (Fig. 1a), while the 
FluA DH M1 can select for an amide-containing dipeptidyl 
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intermediate (Fig. 1b). Both of these substrates require 
interactions with residues of distinct chemical properties 
on the acyl-binding region of the DH domain. A thorough 
inspection of the polyketide acyl-binding region in BorA DH 
M3 and FluA DH M1 identified residues located between 
α3–β11 and α2–β8 (Fig. 3). Surprisingly, the same flexible 
loop region between α3 and β11, where residues are either 
missing (BorA DH M3) or have higher B-factors (FluA DH 
M1), form part of the acyl-binding region. Amino acid pref-
erence and multiple sequence alignment analysis suggest 
that most DH domains have a variant loop region between 
α3 and β11 (Fig. 5b, Fig. S6). Starting from the catalytic 
Asp in the middle of α3 to a conserved Pro at the beginning 
of β11, the loop region can vary in length and amino acid 
composition. These structural insights suggest a putative 
binding region responsible for selecting the diverse chemi-
cal moieties of different polyketide intermediates within DH 
domains.
Docking simulations of PPant‑tethered substrate 
intermediates
In our efforts to further validate the importance of the acyl 
intermediate-binding region for substrate binding and iden-
tify key substrate-binding residues, we initially aimed to 
co-crystalize BorA DH M3 and FluA DH M1 with their 
corresponding starter units. These starter units included 
the trans-cyclopentane-dicarboxylic acid and β-alanine, 
in both the free acid and the N-acetyl-cysteamine thioester 
(SNAC)-coupled form. However, no electron density for the 
corresponding substrates was observed. The lack of substrate 
binding may be due to high specificity of both BorA DH 
M3 and FluA DH M1 for their native PPant-tethered pol-
yketide intermediates 1, 4 (Fig. 1). Using an inactive form 
of BorA DH M3 and FluA DH M1 with the corresponding 
native PPant-substrates would greatly increase our efforts in 
obtaining a substrate–DH domain complex structure. This 
is supported by the inactive H/F959 PpsC DH domain com-
plexed with a PPant-containing trans-dodec-2-enoyl-CoA 
substrate [14]. Given the complexity to synthesize the native 
PPant-tethered borrelidin [20] and fluvirucin intermediates 
for co-crystallization experiments, we decided to conduct in 
silico docking as an alternative approach. Our initial docking 
analysis was focused on the crystal structure of FluA DH 
M1 and its corresponding native substrate 4. The lack of 11 
unmodeled residues in the BorA DH M3 acyl intermediate-
binding region would yield inconclusive in silico docking 
results (Fig. 3a). Therefore, we opted not to conduct sub-
strate docking analysis with the BorA DH M3 model.
A B
Fig. 3  Substrate-binding cavity of the BorA DH M3 and FluA DH 
M1. a Close-up of the BorA DH M3 substrate-binding cavity, key 
residues and depiction of the three regions. The three binding regions 
include the PPant-binding, catalytic and acyl intermediate-binding 
region. Due to poor electron density, 11 amino acids between α3 
and β11 are unmodeled, therefore, given an incomplete model of the 
substrate-binding cavity. b Close-up of the FluA DH M1 substrate-
binding cavity. The variable loop regions are highlighted in red and 
blue residues of the cartoon model (colour figure online)
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In silico docking of the alanine-protected dipeptide PPant 
intermediate 4 with the FluA DH M1 revealed key structural 
regions and residues that may play a role in substrate selec-
tion. The fluvirucin PPant-tethered intermediate 4 revealed 
close interactions with all three regions of the substrate-
binding cavity of FluA DH M1 (Fig. 4). On the surface of 
the DH domain, the conserved Arg 298 was in close proxim-
ity for potential electrostatic interactions with the phosphate 
group of 4. Several hydrophobic residues (Leu 248, Phe 251, 
Ala 105) in the PPant-binding region of the DH were in 
close contact with the PPant moiety of 4. Within the cata-
lytic region, the C-3 hydroxyl group of 4 is in proximity and 
oriented toward the catalytic Asp 231. The orientation of 
the C-3 hydroxyl towards the Asp 231 positioned the C-2 of 
4 next to the catalytic His 69, supporting the mechanism of 
deprotonation of C-2 by the single catalytic base His 69 [42].
Several residues in the acyl intermediate-binding region 
were in the vicinity of the nitrogen-containing dipeptide 
moiety of 4 (Fig. 4). The variable loop region between α3 
and β11 (light blue) contained polar residues His 235 and 
Glu 244 within 4.0 Å from the terminal amino group of 4. 
In addition, residues between α2 and β8 (dark blue), on the 
distal side of the variable loop region between α3 and β1, 
interacted with the dipeptide moiety of 4. Residues between 
Ser 185 and the conserved Tyr 189 were in close contact 
with 4. Surprisingly, the PPant-tethered fluvirucin interme-
diate 4 does not accommodate the entire catalytic region of 
the acyl intermediate-binding region. On average, there is a 
9.5-Å distance gap between the terminal amino moiety of 4 
and the bottom of the substrate-binding cavity. The bottom 
of the cavity contains several variant polar residues (Glu 
241 and Gln 242). The gap identified between these polar 
residues with 4, the high B-factors associated within the 
invariant loop and the lack of modeled residues for similar 
type I DH domains suggest this structural region may adopt 
a distinct conformational change upon binding to the native 
substrate. This is further supported by the small structural 
conformational changes observed between the variable loop 
regions α3–β11 of the apo FluA DH M1 crystal structure 
and the energy minimized docked PPant intermediate 4-
FluA DH M1 complex structure (Fig. S7). Cα superposition 
results in RMSD values of 2.10 Å within the 18 residues of 
the α3–β11 loop region.
Fig. 4  In silico docking analysis 
of FluA DH M1 with the natural 
PPant-substrate intermediate 
4. Substrate 4 interacts with 
all three DH substrate-binding 
regions a. b A close inspection 
of the dipeptide moiety of 4 
shows close interactions with 
residues located between α3 and 
β11 (light blue) and α2 and β8 
(dark blue). c A 90˚ horizontal 
rotation of a and close-up of 
the substrate 4 and interacting 
residues (colour figure online)
A
C
D
B
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Analysis of DH domain conservation
To quantitatively examine the level of sequence conservation 
amongst DH domains, the Shannon entropy of aligned DH 
sequences was calculated at each position within a refined 
multiple sequence alignment (MSA). 330 DH domain 
sequences derived from modular type I PKSs were exported 
from the ClusterCAD database [13]. The secondary structure 
of the FluA DH M1 was used to refine the DH boundaries 
of the MSA and visualize Shannon entropy (H) at each posi-
tion (Fig. 5a). Overall, residues that were conserved and 
displayed low H values were both catalytic residues and resi-
dues important for structural integrity of the double-hotdog 
fold motif. The catalytic His/Asp dyad, located within β3 
and α3, and related DH motifs (HxxxGxxxxP, GYxYGPxF, 
LPFxW) displayed low H values (Fig. 5a). Similarly, the 
known structural motifs that make up the DH boundaries 
(HPLL and LxLxR) prior to β1 and within β14 show low 
Shannon entropy values.
With the aim of identifying residues and/or structural 
regions that may play a role in substrate binding past the 
C-3 hydroxyacyl position, we looked for residues that 
may be easily substituted with others to accommodate the 
diversity of the acyl-ACP substrate intermediate. A closer 
inspection of DH domains showed two regions with high 
H values. These higher H values were present in the loop 
regions between β7–α2 and α3–β11 (Fig. 5b). As observed 
in the BorA DH M3, FluA DH M1 and other DH struc-
tures, these two regions with higher H values are located 
in the same region of unmodeled, high-B-factor residues 
in the PDB structures. Residues between α3 and β11, and 
within α2 form part of the acyl intermediate-binding region 
(Figs. 5, S6). These results further support our DH domain 
structural and in silico docking analysis regarding the impor-
tance of α3–β11 and α2 in substrate selection. These two 
variant regions between α3–β11 and β7–α2 may possess 
distinct amino acid properties across different DH domains 
and may be important for the structural architecture of the 
acyl intermediate-binding region. In particular, the residues 
between α3 and β11 and within α2 may play a direct role 
in substrate selectivity past the C-3 hydroxyacyl position.
Discussion
Substrate selection by DH domains is attributed to both the 
stereochemistry of the C-3 hydroxyacyl group and the chem-
ical structure on the acyl-ACP intermediate past the C-3 
hydroxyacyl position. The recent structural and biochemical 
insights of various DH domains have significantly advanced 
our understanding of stereoselection by DH domains [3, 15, 
17, 25, 26]. However, DH substrate selection pertaining to 
the acyl-ACP intermediate past the C-3 hydroxyacyl position 
remains elusive. For example, the Rif DH M10, CurK DH, 
A
B
Fig. 5  a Prediction of conserved residues through Shannon entropy 
measurements on a multiple sequence alignment of modular type I 
DH domains taken from ClusterCAD. Low Shannon entropy meas-
urements correspond to low levels of amino acid substitution. The 
secondary structure of the FluA DH M1 was used to give a relative 
position within the MSA. Regions highlighted in red display the His/
Asp catalytic dyad and the regions highlighted in yellow correspond 
the two most highly variable regions amongst the known modular 
type I DH domain structures. b Close-up of the region between α3 
and β11. The overall height of the stack indicates the sequence con-
servation at that position (colour figure online)
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and most DH domains act on a C-3 hydroxyl-ACP inter-
mediate. Yet, the Rif DH M10 from rifamycin is selective 
towards a C-18, naphthoquinone-containing intermediate 
[17, 38] while the CurK DH acts on a shorter thiazoline, 
cyclopropyl-containing intermediate [3, 8]. A key ques-
tion in DH substrate selectivity is what residue(s) and/or 
structural features within the DH domain are responsible for 
selection of the acyl intermediate past the C-3 hydroxyacyl 
position. Further structural and biochemical insights on DH 
domains would provide a better understanding of substrate 
selection past the PPant and C-3 hydroxyacyl moiety.
To further improve our current understanding of DH 
selectivity towards different acyl-ACP intermediates past 
the C-3 hydroxyacyl position, we have performed structural 
analysis on two chemically diverse DH domains. The first 
DH domain, isolated from the third module in the borrelidin 
PKS, is specific towards a trans-cyclopentane-carboxylate-
containing polyketide substrate. The second DH domain, 
isolated from the first module in fluvirucin  B1 PKS, accepts 
an amide-containing polyketide intermediate. Both DH 
domains maintain the canonical double-hotdog fold motif 
with the invariant His/Asp catalytic dyad. Surprisingly, a 
structural comparison of the BorA DH M3, FluA DH M1 
and other type I DH domains show few significant devia-
tions from each other. The two major differences between 
BorA DH M3, FluA DH M1 and other DH domains are 
found in regions of unmodeled residues or residues contain-
ing high B-factors. These two regions are located between 
α3–β11 and β7–α2. From the catalytic Asp located in α3 
to a conserved Pro in β11, the residues between them form 
part of the bottom of the substrate-binding cavity respon-
sible for binding to the acyl-ACP intermediates past the 
C-3 hydroxyacyl position. The distal region from α3 to β11 
is also part of substrate-binding cavity and is located in 
α2–β8. The loop connecting β7–α2 is one of the most vari-
able regions in modular type I DH domain structures. The 
variable β7–α2 loop region may provide flexibility to part 
of the substrate-binding cavity located in α2–β8 (Fig. 4). 
These structural insights suggest both α3–β11 and β7–α2 
are important for binding of the acyl-ACP intermediate past 
the C-3 hydroxyacyl position. This was further supported 
by our in silico docking analysis of the FluA DH M1 and 
prediction of conserved residues through Shannon entropy 
measurements (Figs. 4, 5). Structural evidence for this can 
be observed in the PpsC DH structures in complex with 
trans-dodec-2-enoyl-CoA (PDB ID: 5NJI) or crotonyl-CoA 
((PDB ID: 5I0K). Comparison of the α3–β11 and β7–α2 
regions in both structures displays key differences. More 
residues were modeled in the α3–β11 of PpsC DH struc-
ture in the presence of the longer trans-dodec-2-enoyl-CoA 
substrate, suggesting higher stability of the α3–β11 region 
upon binding of a substrate that closely resembles the native 
acyl-ACP intermediate.
The identification of both the α3–β11 and β7–α2 regions 
involved in substrate selection may provide insights into 
rational engineering of DH domains. In our efforts to 
improve DH-mediated dehydration in adipic acid production 
using the engineered BorA2 PKS [19], we tested various DH 
domains and chimeric DH domains with α3–β11 loop swaps 
in vitro (Fig. S8a). Surprisingly, all chimeric DH domains 
containing the α3–β11 loop swaps were soluble (Fig. S8b). 
This suggests that a key secondary structure is maintained 
within the DH domain’s α3–β11 loop swap region. However, 
a close inspection of adipic acid production using the chi-
meric DH domains was inconclusive (Fig. S8c). We specu-
late that the lack of conclusive results may be due to both 
the high background of adipic acid that is likely derived 
from E. coli during protein purification, and low efficiency 
of the BorA2 PKS to produce adipic acid. This assay may 
not be optimal for testing chimeric DH activity. Nonetheless, 
generating soluble and stable chimeric DH domains is a first 
step towards DH engineering. Further efforts in investigat-
ing the activity of chimeric DH domains can be simplified 
by testing standalone chimeric DH domains containing the 
α3–β11 loop swaps with more naturally relevant acyl-ACP, 
acyl-PPant or acyl-SNAC substrates [20].
Our structures of the BorA DH M3 and FluA DH M1 
provide further structural evidence of substrate selection by 
DH domains within modular type I PKSs. We present both a 
sequence-structural analysis between DH domains and iden-
tify significant similarities and key differences pertaining to 
substrate selection. The work presented here in combination 
with existing DH domain studies should facilitate further 
engineering efforts of modified PKSs that can process non-
natural substrates with improved catalytic properties.
Materials and methods
Cloning of BorA DH M3 and FluA DH M1
Vector backbone template originated from JPUB_008800 
plasmid (Table S1). The genes encoding for BorA DH M3 
and FluA DH M1 were PCR amplified from the pDVA00936 
and pTL-A01 plasmids, and cloned into a pET28a vector 
using Gibson assembly methodology [18]. The j5 DNA 
assembly design automation software [22] was utilized 
to generate Gibson assembly primers for the BorA DH 
M3, FluA DH M1 and pET28a vector backbone. Primer 
sequences are available in Table  S1. Polymerase chain 
reaction amplification of the BorA DH M3, FluA DH M1 
and pET28a backbone was conducted using Phusion Hot 
Start II DNA polymerase (Thermo Fisher) using the ven-
dor’s recommended protocol at an annealing temperature 
of 65 °C and 1 min extension time for the DHs and 3 min 
extension time for the pET28 backbone. The pET28a PCR 
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product was Dpn1 digested (Thermo Fisher) using the ven-
dor-recommended protocol and subjected to PCR clean up 
(Zymo Research). The DH genes and pET28a PCR prod-
uct were ligated using Gibson assembly master mix (New 
England BioLabs), following the vendor-recommended 
protocol. Both DH constructs were designed with a throm-
bin-cleavable N-terminal 6 × His-tag. The strains and plas-
mid sequences utilized in this study are listed in Table S1. 
All strains and plasmid sequences may be accessed and 
requested through the Joint BioEnergy’s public registry 
(https ://publi c-regis try.jbei.org/folde rs/412) [21].
Protein expression and purification
The recombinant BorA DH M3 and FluA DH M1 containing 
an N-terminal 6 × His-tag were produced in BL21 (DE3) E. 
coli cells (Novagen). Cells containing the pET28-DH plas-
mids were grown to  OD600 = 0.8 at 37 °C in TB medium con-
taining 50 µg/mL kanamycin. The cell cultures were cooled 
to 18 °C and expression was induced using 1 mM IPTG. 
The cell cultures were incubated for an additional 16 h at 
18 °C and harvested by centrifugation at 5525 r.c.f. for 
10 min. The cell pellets were resuspended in 50 mM Hepes, 
pH 7.6, 10% glycerol, 10 mM imidazole, 300 mM NaCl. 
Resuspended cells were cooled on ice for 30 min and the 
cells were disrupted using sonication. The cell debris was 
cleared by centrifugation at 21,036 r.c.f. for 1 h. The super-
natant was collected and batch bound to HisPur TM Cobalt 
Resin (Thermo Scientific) for 1 h at 4 °C. BorA DH M3 and 
FluA DH M1 were purified according to the manufacturer’s 
instructions using an imidazole step-gradient. Fractions con-
taining pure protein were determined by SDS-PAGE and 
fractions containing either BorA DH M3 or FluA DH M1. 
Removal of the N-terminal 6 × His-tag was conducted by 
incubating the fractions containing the proteins at 14 °C for 
30 h with thrombin from bovine plasma (Sigma-Aldrich) 
at a concentration of 2 U/mg of recombinant protein and 
3.5 mM  CaCl2. After thrombin digestion and assessment 
of N-terminal 6 × His-tag cleavage via SDS-PAGE, we dia-
lyzed the DH domains against 50 mM Hepes, pH 7.6, 5% 
glycerol. Removal of thrombin and further purification of 
BorA DH M3 and FluA DH M1 were conducted by anion-
exchange chromatography using HiTrap Q FF (GE Health-
care) according to the manufacturer’s instructions. Purified 
BorA DH M3 and FluA DH M1 were dialyzed against crys-
tallization buffer, which consisted of 25 mM Hepes, pH 7.6, 
and 1 mM dithiothreitol (Fig. S9). Both BorA DH M3 and 
FluA DH M1 were concentrated to 12 mg/mL for crystal-
lographic studies.
Crystallization and structure determination
Crystallization screening was carried out on a Phoenix robot 
(Art Robbins Instruments, Sunnyvale, CA) using a sparse 
matrix screening method [23]. BorA DH M3 concentrated 
to 10 mg/mL was crystallized by sitting drop vapor diffu-
sion in drops containing a 1:1 ratio of protein solution and 
0.20 M  MgCl2, 0.10 M Tris, pH 8.5, and 29% (w/v) PEG 
4000. For FluA DH M1, 10 mg/mL protein was crystallized 
by sitting drop vapor diffusion in drops containing a 1.5:1 
ratio of protein solution and 0.40 M NaCl, 0.10 M Tris, pH 
8.5, and 29% (w/v) PEG 3350. For both proteins, a final 
concentration of 15% glycerol was added before flash freez-
ing in liquid nitrogen.
The X-ray data sets for BorA DH M3 and FluA DH M1 
were collected at the Berkeley Center for Structural Biology 
on beamlines 8.2.1 and 8.2.2 of the Advanced Light Source 
at Lawrence Berkeley National Laboratory. Diffraction data 
were recorded using ADSC Q315R detectors (Area Detector 
Systems Corporation, San Diego, CA). Processing of image 
data was performed using the HKL2000 suite of programs 
[32]. For both proteins, phases were calculated by molecular 
replacement with the program Phaser [28], using the struc-
ture of Rif DH M10 (PDB id: 4LN9) [6] as a search model. 
Automated model building was conducted using AutoBuild 
[39–41] from the Phenix [1] suite of programs resulting in 
a model that was mostly complete. Manual building using 
Coot [12] was alternated with reciprocal space refinement 
using Phenix [2]. Waters were automatically placed using 
Phenix and manually added or deleted with Coot according 
to peak height (3.0σ in the Fo-Fc map) and distance from a 
potential hydrogen bonding partner (< 3.5 Å). TLS refine-
ment [33] using ten groups, chosen using the TLSMD web 
server [33], was used in later rounds of refinement. All data 
collection, phasing, and refinement statistics are summarized 
in Table S2.
In silico substrate docking
We conducted in silico substrate docking between 4 and the 
FluA DH M1. The natural PPant-tethered substrate 4 was 
initially drawn in Chemdraw (PerkinElmer) and transferred 
in SMILES format to the PHENIX software suite, eLBOW 
ligand and constraints generator [1]. The eLBOW program 
generated a PDB file of the PPant-tethered substrate 4 and a 
constraints (.cif) file. Both files were used to dock 4 into the 
FluA DH M1. As a reference for substrate binding, we used 
the co-crystal structure of PpsC DH complexed with trans-
dodec-2-enoyl-CoA (PDB ID: 5NJI) to position substrate 
4 into the FluA DH M1. We utilized the program Coot to 
overlay the PpsC DH with chain A of the FluA DH M1 and 
model in substrate 4 [11]. The entire FluA DH M1-substrate 
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4 complex was then energy minimized using the program 
UCSF CHIMERA [34]. The lack of 11 unmodeled residues 
in the BorA DH M3 acyl intermediate-binding region made 
it difficult to conduct precise in silico docking on this target 
and obtain conclusive information. Therefore, we opted not 
to conduct substrate docking analysis with the BorA DH 
M3 model.
Protein structure and visualization
All of the protein structure analysis and figures were gen-
erated using UCSF CHIMERA [34] and PyMOL (The 
PyMOL Molecular Graphics System, PyMOL1.2edu1 2009, 
Schrödinger, LLC). Both PyMOL and the online I-TASSER 
server were used for PDB structural alignment analysis [36]. 
Multi-sequence alignment for Fig. S6 was generated using 
MUSCLE [10] and visualized using ESPript 3.0 [35].
Analysis of DH sequence conservation
The Shannon entropy of aligned DH sequences was calcu-
lated at each position within a refined multiple sequence 
alignment (MSA). Briefly, 330 sequences derived from PKS 
non-loading modules containing AT, DH, KR, and ACP 
domains with active KR and DH domains were exported 
from the ClusterCAD database [13]. Sequences contained 
the first residue after the AT domain to the last residue 
immediately preceding the downstream domain (usually 
a KR or ER). Sequences were then aligned using MAFFT 
[24]. The MSA was then refined using the ProDy python 
library so that all positions within the MSA maintained at 
least 10% occupancy [4]. ProDy was then used to calculate 
the Shannon entropy of each position within the resulting 
MSA. The boundaries of the DH domain within the MSA 
were further refined using PDB structural information.
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